Company Overview
Snapshot
Founded in July 2014 by Efrat Roman, EZbra Advanced Wound Care operates with 1–10 employees. The company has secured funding across 4 rounds from 10 investors, with Jant Ventures leading one of the rounds. In September 2020, EZbra announced its first partnership in the UAE with distributor Pharmacyna LLC.
Business overview
EZbra Advanced Wound Care develops EZbra, a patented, sterile, disposable bra designed for advanced postoperative wound care. This all-in-one product addresses the challenges faced by patients undergoing breast procedures, including biopsies, lumpectomies, mastectomies, reconstructions, and aesthetic surgeries. Operating within the Health Tech & Life Sciences sector, EZbra provides tailored solutions for various breast shapes and requirements, serving the medical device market and contributing to the FemTech industry.
Strategic signal
In September 2020, EZbra announced its first partnership in the UAE with Pharmacyna LLC, a distributor based in Dubai. This strategic collaboration signals the company's expansion into new international markets, demonstrating a clear intent to broaden its reach for its patented breast dressing and validate its product's appeal in diverse healthcare landscapes.
Company Intelligence Q&A
- When was EZbra Advanced Wound Care founded and by whom?
- EZbra Advanced Wound Care was founded in July 2014 by Efrat Roman.
- What is EZbra Advanced Wound Care's primary product?
- EZbra Advanced Wound Care develops EZbra, a patented, sterile, disposable bra for advanced postoperative wound care.
- Which investor led a funding round for EZbra Advanced Wound Care?
- Jant Ventures led a funding round for EZbra Advanced Wound Care in December 2018.
- What significant partnership did EZbra announce in 2020?
- In September 2020, EZbra announced its first partnership with Pharmacyna LLC in Dubai to distribute its patented breast dressing across the United Arab Emirates.
- When did EZbra's breast dressing make its US debut?
- EZbra's breast dressing made its US debut at a premier aesthetic surgery conference in November 2018.